Abbvie – Open Horizons: Up-to-Date Treatment Options for Inflammatory Skin Diseases
Maruho – The Birth of a Novel Treatment for Itching with IL-31RA Antibody
Japan Blood Products Organization – Dermatomyositis
Otsuka Pharmaceutical – Pathophysiology of Atopic Dermatitis
Kaken Pharmaceutical – New Findings on Terbinafine-resistant Dermatophytosis
Taisho Pharmaceutical – Visualization of vascular network in the skin and brain enables the understanding of stem cell niche -Cross-talk system between “vasculature” and “hair cycle/minoxidil/skin homeostasis”
AMRYT – Epidermolysis Bullosa – Concepts for Change
UCB Medical – Understanding Hidradenitis Suppurativa: an Educational Symposium
Taiho Pharmaceutical/Janssen Pharmaceutical K. K. – Pathophysiology of Psoriasis and the Role of IL-23
Bristol Myers Squibb – A New Pathway for Psoriasis Treatment
Pfizer – JAK and Other Kinase Inhibitors in Dermatology: Dawn of a New Therapeutic Era
Sulwhasoo (Amorepacific) – Skin Epigenetics
CHANEL Fragrance & Beauty – Senescence: The Global Approach to Skin Aging
Galderma – Targeting itch and beyond: IL-31, a central neuroimmune mediator in atopic dermatitis and prurigo nodularis
Concurrent Mini-symposium 1: Adaptive and Auto-Immunity 1
Concurrent Mini-symposium 2: Artificial Intelligence (AI) and Translational Studies
Concurrent Mini-symposium 3: Carcinogenesis and Cancer Genetics
Concurrent Mini-symposium 4: Clinical Research: Epidemiology and Observational Research
Concurrent Mini-symposium 5: Genetic Diseases
Concurrent Mini-symposium 6: Tissue Regeneration and Wound Healing
Sanofi – Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis: Research breakthroughs leading to therapeutic innovations for patients with atopic dermatitis
ePoster Stage 1: Adaptive and Auto-Immunity I & II
ePoster Stage 2: Clinical Research – Epidemiology and Observational Research I & II
ePoster Stage 3: Tissue Regeneration and Wound Healing/Skin, Appendages, and Stem Cell Biology
ePoster Stage 4: Carcinogenesis and Cancer Genetics/Photobiology & Skin of Color
ePoster Stage 5: Genetic Disease, Gene Regulation, and Gene Therapy
JSID – 7:00 – 8:00 JPN
SID – 7:00 – 7:45JPN
ESDR – 7:00 – 8:00 JPN
TSID – 7:00 – 8:00 JPN
Janssen – Unlocking the IL-23 pathway: looking back to move forward for psoriasis management
Nippon Boehringer Ingelheim – Latest research on pustular skin diseases
No 7 Beauty Company – Matrix-derived Cosmetic Peptides (matrikines) for the Rejuvenation of Photoaged Skin
Shiseido – Skin Beauty Provided by Healthy Blood and Lymphatic Vascular Systems
LEO Pharma – Updated Information About the Roles of IL-13 in Atopic Dermatitis
Torii Pharmaceutical, LTD. Company -Understanding the Pathogenesis of Atopic Dermatitis
Eli Lilly – Explore Our Future from Investigative Research in Alopecia Areata, Atopic Dermatitis and Psoriasis
Concurrent Mini-symposium 7: Adaptive and Auto-Immunity 2
Concurrent Mini-symposium 8: Clinical Research: Epidemiology 2
Concurrent Mini-symposium 9: Innate Immunity, Microbiology, and Microbiome 1
Concurrent Mini-symposium 10: Pharmacology and Drug Development
Concurrent Mini-symposium 11: Photobiology and Skin of Color
Concurrent Mini-symposium 12: Skin, Appendages and Stem Cell Biology
ePoster Stage 1: Artificial Intelligence, Image Analysis, and Translational Studies/Pigmentation & Melanoma
ePoster Stage 2: Innate Immunity, Microbiology, & Microbiome I & II
ePoster Stage 3: Cell-Cell Interactions in the Skin/Epidermal Structure and Barrier Function
ePoster Stage 4: Pharmacology and Drug Development/Clinical Research, Interventional Research, and Sociobehavioral and Health Services Research
ePoster Stage 5: Late-Breaking Abstracts
Nov division, TOKIWA Pharmaceutical Co., Ltd – New Technology Opens the Future of Dermatology
Amgen Symposium
Sato Pharmaceutical/Eisai Co. – Fosravuconazole, an Oral Antifungal Agent for the Treatment of Onychomycosis: Basic Characteristics and Clinical Effects
Nobelpharma – Therapeutic Effects of Topical Sirolimus on Skin Lesions in Tuberous Sclerosis: Including clinical collaboration
Incyte Symposium – Vitiligo Pathophysiology and Emerging Treatments
Novartis Pharma K.K. – Reimagining Immuno-dermatology
UCB – Spotlight on Psoriasis: New Perspectives on Therapy and Pathology
Taiho Pharmaceutical/Janssen Pharmaceutical – Characteristics of Palmoplantar Pustulosis
Mitsubishi Tanabe Pharma /Teikoku Seiyaku – Itch Caused by Common Skin Disease
The Estée Lauder Companies Inc. – Skin Barrier Function and Approaches for Improving Innate Hydration of Skin
SUN Pharma – How to Apply Genetic Information to Autoimmune Research
Procter & Gamble – A Novel Approach in Understanding Skin Leveraging Spatial Biology
Concurrent Mini-symposium 13: Cell-Cell Adhesion of the Skin
Concurrent Mini-symposium 14: Clinical Research – Socio-behavioral and Health Services Research/Clinical Research- Interventional Research
Concurrent Mini-symposium 15: Epidermal Structure and Barrier Function
Concurrent Mini-symposium 16: Innate Immunity, Microbiology, Microbiome II
Concurrent Mini-symposium 17: Pigmentation and Melanoma
Concurrent Mini-symposium 18: Late-Breaking Abstracts
